IDEX Corporation acquired CVI Melles Griot (CVI) for approximately $400 million (cash), a transaction completed in June 2011, structured as all cash.
CVI Melles Griot (CVI) operates in Health & Science Technologies (Optics & Photonics platform), is based in Albuquerque, New Mexico, USA (manufacturing on three continents), had revenue of about approximately $185 million annual revenue. Global leader in the design and manufacture of precision photonic solutions used in the Life Sciences, Research, Semiconductor, Security and Defense markets; products include specialty lasers and light sources, electro-optical components, opto-mechanical assemblies, aspheric lenses, laser mirrors, interference filters and polarizers. Acquired from Norwest Equity Partners.
Cornerstone to IDEX's rapidly expanding optics and photonics platform; a true leader in high precision optical devices combining leading-edge products, design and manufacturing capabilities and distribution channels.
Expected to be accretive to IDEX's earnings within the first full year after acquisition. Health and Science Technologies segment, optics and photonics platform
We are thrilled with the opportunity to add CVI to IDEX as the cornerstone to our rapidly expanding optics and photonics platform. CVI is a true leader in the field of high precision optical devices.Larry Kingsley, Chairman and Chief Executive Officer, IDEX
Advisory firms were not disclosed for this transaction.